Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Litvan

Showing results (181-190 of 331) with videos related to

Pageof 34
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|February 21, 2018
Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP studyHee Kyung Park, Sindana Ilango, Christina M Charriez, et al.
Journal of Parkinson'S Disease|September 13, 2014
Pan-American Consortium of Multiple System Atrophy (PANMSA). A Pan-American multicentre cohort study of multiple system atrophyEmilia Gatto, Mayela Rodríguez-Violante, Carlos Cosentino, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 9, 2016
Environmental and occupational risk factors for progressive supranuclear palsy: Case-control studyIrene Litvan, Peter S J Lees, Christopher R Cunningham, et al.
Brain and Behavior|July 16, 2024
High baseline perivascular space volume in basal ganglia is associated with attention and executive function decline in Parkinson's diseaseRyan Patrick Foreman, Erin Kaye Donahue, Jared Joshua Duran, et al.
Parkinsonism & Related Disorders|October 6, 2012
The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's diseaseMelissa J Armstrong, Sarah Duff-Canning, David F Tang-Wai, et al.
Frontiers in Neurology|April 26, 2021
Gene-Environment Interactions in Progressive Supranuclear PalsyIrene Litvan, James A Proudfoot, Eden R Martin, et al.
Annals of Neurology|April 20, 2016
α-synuclein genetic variability: A biomarker for dementia in Parkinson diseaseIlaria Guella, Daniel M Evans, Chelsea Szu-Tu, et al.
Journal of Neuropathology and Experimental Neurology|October 21, 2022
Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across TauopathiesDavid G Coughlin, Annie Hiniker, Claire Peterson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 7, 2012
The pill questionnaire in a nondemented Parkinson's disease populationWilliam Reginold, Melissa J Armstrong, Sarah Duff-Canning, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
PINK1 is a target of T cell responses in Parkinson's diseaseGregory P Williams, Tanner Michaelis, João Rodrigues Lima-Junior, et al.
Pageof 34

Showing results (181-190 of 331) with videos related to

Sort By:
Pageof 34
Movement Disorders : Official Journal of the Movement Disorder Society|February 21, 2018
Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP studyHee Kyung Park, Sindana Ilango, Christina M Charriez, et al.
Journal of Parkinson'S Disease|September 13, 2014
Pan-American Consortium of Multiple System Atrophy (PANMSA). A Pan-American multicentre cohort study of multiple system atrophyEmilia Gatto, Mayela Rodríguez-Violante, Carlos Cosentino, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 9, 2016
Environmental and occupational risk factors for progressive supranuclear palsy: Case-control studyIrene Litvan, Peter S J Lees, Christopher R Cunningham, et al.
Brain and Behavior|July 16, 2024
High baseline perivascular space volume in basal ganglia is associated with attention and executive function decline in Parkinson's diseaseRyan Patrick Foreman, Erin Kaye Donahue, Jared Joshua Duran, et al.
Parkinsonism & Related Disorders|October 6, 2012
The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's diseaseMelissa J Armstrong, Sarah Duff-Canning, David F Tang-Wai, et al.
Frontiers in Neurology|April 26, 2021
Gene-Environment Interactions in Progressive Supranuclear PalsyIrene Litvan, James A Proudfoot, Eden R Martin, et al.
Annals of Neurology|April 20, 2016
α-synuclein genetic variability: A biomarker for dementia in Parkinson diseaseIlaria Guella, Daniel M Evans, Chelsea Szu-Tu, et al.
Journal of Neuropathology and Experimental Neurology|October 21, 2022
Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across TauopathiesDavid G Coughlin, Annie Hiniker, Claire Peterson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 7, 2012
The pill questionnaire in a nondemented Parkinson's disease populationWilliam Reginold, Melissa J Armstrong, Sarah Duff-Canning, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
PINK1 is a target of T cell responses in Parkinson's diseaseGregory P Williams, Tanner Michaelis, João Rodrigues Lima-Junior, et al.
Pageof 34